Related Experiment Video
Updated: Aug 20, 2026

Visualizing Scar Development Using SCAD Assay - An Ex-situ Skin Scarring Assay
Published on: April 28, 2022
Novel opportunities in the treatment and prevention of scarring
Brian Berman1, Adriana M Villa, Claudia C Ramirez
1Department of Dermatology and Cutaneous Surgery, University of Miami School of Medicine, Miami, Florida 33136, USA. bberman@med.miami.edu
Abstract:
Numerous treatments have been described for the treatment and prevention of scars, but the optimal management strategy is yet to be defined. In this article we present and evaluate new opportunities for the treatment and prevention of hypertrophic scars, keloids, and atrophic scars. Clinical, animal, and in vitro studies reporting novel techniques for the treatment and prevention of scarring were identified primarily from the MEDLINE/PubMed database. We found that a variety of new treatments exist with potential effectiveness for the treatment of hypertrophic scars and keloids, including interferon, imiquimod 5% cream, tacrolimus, botulinum toxin, 5-fluorouracil, bleomycin, and verapamil. For atrophic scars, different types of lasers represent modern treatment modalities with satisfactory results. Several agents have been reported to be effective in reducing scarring in vitro and in animal studies, representing potential opportunities for scarring management. We conclude that several novel modalities may be potential therapies for scarring.
Insights
Novel treatments show promise for managing various scar types, including hypertrophic scars, keloids, and atrophic scars. Research highlights new topical agents and laser therapies as potential advancements in scar prevention and treatment.
Area of Science:
- Dermatology
- Regenerative Medicine
- Medical Research
Background:
- Optimal scar management remains undefined despite numerous existing treatments.
- Hypertrophic scars, keloids, and atrophic scars present distinct clinical challenges.
- Advancements in understanding scar pathophysiology drive the search for novel therapies.
Purpose of the Study:
- To evaluate emerging treatment and prevention strategies for hypertrophic scars, keloids, and atrophic scars.
- To identify novel therapeutic agents and modalities with potential efficacy in scar management.
- To synthesize findings from clinical, animal, and in vitro studies on scar treatments.
Main Methods:
- Systematic literature search of MEDLINE/PubMed for studies on novel scar treatments.
- Inclusion of clinical, animal, and in vitro research.
- Evaluation of reported effectiveness of various agents and techniques.
Main Results:
- Several agents show potential for hypertrophic scars and keloids: interferon, imiquimod 5% cream, tacrolimus, botulinum toxin, 5-fluorouracil, bleomycin, and verapamil.
- Laser therapies demonstrate satisfactory results for atrophic scars.
- In vitro and animal studies indicate effectiveness of several agents for scar reduction.
Conclusions:
- Novel treatment modalities show potential for managing different types of scars.
- Emerging therapies offer new opportunities for scar prevention and treatment.
- Further research is warranted to establish optimal scar management protocols.
Related Concept Videos
Clinical Applications of Epidermal Stem Cells
Healing II: Complications
Acne Infection
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Burn Injuries
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...

